Application Sponsors
ANDA 205267 | GLENMARK PHARMS LTD | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
None (Tentative Approval) | 004 |
Application Products
002 | TABLET;ORAL | 25MG | 0 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE |
003 | TABLET;ORAL | 50MG | 0 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE |
004 | TABLET;ORAL | 100MG | 0 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2017-03-30 | STANDARD |
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 205267
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"MILNACIPRAN HYDROCHLORIDE","activeIngredients":"MILNACIPRAN HYDROCHLORIDE","strength":"12.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"MILNACIPRAN HYDROCHLORIDE","activeIngredients":"MILNACIPRAN HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"MILNACIPRAN HYDROCHLORIDE","activeIngredients":"MILNACIPRAN HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"MILNACIPRAN HYDROCHLORIDE","activeIngredients":"MILNACIPRAN HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/30\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-03-30
)
)